Our leading subject matter experts share their insightful analysis and points of view to help you stay abreast of industry trends
This article was originally published on Norstella’s website.
As real-world data (RWD) evolves, the rise of unstructured data—from clinical notes to lab reports—is transforming how life sciences teams identify, understand, and…
Pharma companies have made significant strides in omnichannel marketing, building programs that engage healthcare professionals (HCPs) across email, digital, social, and peer-to-peer platforms. However, many of these campaigns are often…
This article was originally published in BioPharma Dive.
Pharma companies are increasingly turning to real-world data to answer their commercial business questions, but not all realize that unstructured EMR data…
As therapies have become more complex, pharma companies are now challenged to achieve precision targeting within a much tighter timeframe. While claims data is readily available, one of its key…
Months and months of market access planning occur long before a new therapy is approved. Once that therapy is finally on the market, pharma companies must then turn their attention…
In recent years, pharma companies have begun to embrace lab data as a richly rewarding dataset for a whole host of purposes, including trial enrollment and site identification, patient monitoring…
Lab data has become an increasingly essential dataset for pharmaceutical companies at all stages of the product life cycle. A key use case for our MMIT clients is using lab…
In our collective experience working with dozens of clients, we’ve found that smaller pharma companies and biotechs wrestle with many common challenges, regardless of their therapeutic area. From limited budgets…
In our last blog on this subject, we asked three clinical experts to explain how integrated real-world and market access data helps pharma companies go to market. In this blog,…
When a manufacturer is at least a year out from a drug’s PDUFA date, the market access team begins to make informed decisions about what data is necessary for a…
